| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $194.5M | +18.5% | +42.4% |
| R&D Expense | $24.7M | +10.3% | +12.8% |
| SG&A Expense | $35.0M | +35.7% | +11.5% |
| Pre-tax Income | -$36.3M | +14.8% | +44.8% |
| Income Tax | $1.2M | -7.7% | -36.8% |
| Net Income | -$37.5M | +14.6% | +44.6% |
| EPS (Basic) | -$0.51 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $345.9M | -8.4% | +4.9% |
| Short-term Investments | $23.5M | +10.3% | -24.4% |
| Total Assets | $1.92B | -0.8% | +5.3% |
| Total Liabilities | $1.40B | -0.3% | +14.0% |
| Stockholders' Equity | $516.2M | -2.1% | -13.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.2M | — | — |
| Capital Expenditures | $6.3M | — | — |
| Investing Cash Flow | -$70.2M | — | — |
| Financing Cash Flow | $68.1M | — | — |
| Free Cash Flow | -$43.5M | — | — |
| +15.0% |
| +46.3% |
| EPS (Diluted) | -$0.51 | +15.0% | +46.3% |